The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

The agency and Novo Nordisk, which makes Ozempic, said Monday that they had learned about "several hundred units" of the drug ...

“There is some evidence that there is altered brain activity related to reward-related behaviors, including appetite and ...

A groundbreaking daily pill could compete with weight-loss injections such as Ozempic, research suggests. In trials, people ...

Ozempic, made by Novo Nordisk, is part of a class of drugs known as GLP-1 agonists. The drugs are used to treat type 2 diabetes and obesity. The FDA said it was notified by Novo Nordisk about the ...

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and ...

Ozempic contains the active ingredient semaglutide. Victoza contains the active ingredient liraglutide. Semaglutide and liraglutide belong to the same drug class, called glucagon-like peptide-1 ...

including the class of drugs known as GLP-1 receptor agonists, the drugs behind today’s blockbuster, injectable weight-loss medications, Ozempic and Wegovy. There are different GLP-1 molecules.

Ozempic, a medication to help manage diabetes, has shot up in popularity in the US. So much so, that the US Food and Drug Administration (FDA) has issued a warning against using counterfeit Ozempic, ...

Weight-loss drugs can be life-changing for people who ... receptor agonists, a class of medications known under brand names such as Wegovy, Ozempic and Mounjaro, which works by mimicking the hormone ...